Page last updated: 2024-08-24

capecitabine and Colonic Diseases

capecitabine has been researched along with Colonic Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gaspert, A; Montani, M; Odze, R; Reineke, T; Rogler, G; Soldini, D; Weber, A	1
Hashimoto, Y; Hotta, S; Iwaki, T; Kameyama, H; Kobayashi, T; Oyamatsu, M; Sakata, J; Sato, K; Sato, Y; Shimada, Y; Wakai, T	1
Cennamo, V; Fuccio, L	1

Reviews

1 review(s) available for capecitabine and Colonic Diseases

Article	Year
[A Case of Intussusception Caused by Descending Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Descending; Colonic Diseases; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Intussusception; Male; Middle Aged; Oxaloacetates	2016

Other Studies

2 other study(ies) available for capecitabine and Colonic Diseases

Article	Year
Apoptotic enteropathy caused by antimetabolites and TNF-α antagonists. Journal of clinical pathology, 2014, Volume: 67, Issue:7 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Apoptosis; Biopsy; Capecitabine; Colon; Colonic Diseases; Colonic Pouches; Deoxycytidine; Diarrhea; Endoscopy, Gastrointestinal; Etanercept; Fluorouracil; Humans; Immunoglobulin G; Immunohistochemistry; Infliximab; Intestinal Mucosa; Methotrexate; Receptors, Tumor Necrosis Factor; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha	2014
Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning? Gastrointestinal endoscopy, 2010, Volume: 72, Issue:6 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Diseases; Colorectal Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Intestinal Obstruction; Intestinal Perforation; Organoplatinum Compounds; Oxaliplatin; Rupture, Spontaneous; Stents	2010

Article

Year

Apoptotic enteropathy caused by antimetabolites and TNF-α antagonists.

Journal of clinical pathology, 2014, Volume: 67, Issue:7

Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Apoptosis; Biopsy; Capecitabine; Colon; Colonic Diseases; Colonic Pouches; Deoxycytidine; Diarrhea; Endoscopy, Gastrointestinal; Etanercept; Fluorouracil; Humans; Immunoglobulin G; Immunohistochemistry; Infliximab; Intestinal Mucosa; Methotrexate; Receptors, Tumor Necrosis Factor; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha

2014

Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning?

Gastrointestinal endoscopy, 2010, Volume: 72, Issue:6

Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Diseases; Colorectal Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Intestinal Obstruction; Intestinal Perforation; Organoplatinum Compounds; Oxaliplatin; Rupture, Spontaneous; Stents

2010